Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic Endocrinology, Diabetes and Metabolism July 2021;4(3)
Date
07/01/2021
DOI
10.1002/edm2.246Scopus ID
2-s2.0-85102201015 (requires institutional sign-in at Scopus site)
1 CitationAuthor List
Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW
Author
James W. Findling MD Professor in the Medicine department at Medical College of Wisconsin